Medline Inc (MDLN) PT Lowered to $45 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDLN Hot Sheet
Price: $39.89 +17.01%
Rating Summary:
23 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
23 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Baird analyst Eric Coldwell lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $57.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
- Zimmer Biomet (ZBH) PT Raised to $120 at Jefferies
- Livanova (LIVN) PT Raised to $120 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
